These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

422 related items for PubMed ID: 10173086

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
    Weaver MR, Conover CJ, Proescholdbell RJ, Arno PS, Ang A, Uldall KK, Ettner SL.
    J Ment Health Policy Econ; 2009 Mar; 12(1):33-46. PubMed ID: 19346565
    [Abstract] [Full Text] [Related]

  • 3. Substance abuse with mental disorders: specialized public systems and integrated care.
    Burnam MA, Watkins KE.
    Health Aff (Millwood); 2006 Mar; 25(3):648-58. PubMed ID: 16684728
    [Abstract] [Full Text] [Related]

  • 4. A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness.
    Bellack AS, Bennett ME, Gearon JS, Brown CH, Yang Y.
    Arch Gen Psychiatry; 2006 Apr; 63(4):426-32. PubMed ID: 16585472
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The impact of managed behavorial healthcare on the costs of psychiatric and chemical dependency treatment.
    Geraty R, Bartlett J, Hill E, Lee F, Shusterman A, Waxman A.
    Behav Healthc Tomorrow; 1994 Apr; 3(2):18-30. PubMed ID: 10172255
    [Abstract] [Full Text] [Related]

  • 10. Mental illness and substance use: an Australian perspective.
    Munro I, Edward KL.
    Int J Ment Health Nurs; 2008 Aug; 17(4):255-60. PubMed ID: 18666908
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Estimating the cost impact of three dual diagnosis treatment programs.
    Jerrell JM, Hu TW.
    Eval Rev; 1996 Apr; 20(2):160-80. PubMed ID: 10182202
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Responding to the threat of HIV among persons with mental illness and substance abuse.
    Parry CD, Blank MB, Pithey AL.
    Curr Opin Psychiatry; 2007 May; 20(3):235-41. PubMed ID: 17415075
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Two worlds of treatment are converging.
    Enos G.
    Behav Healthc Tomorrow; 2002 Jun; 11(3):SR31. PubMed ID: 12085434
    [No Abstract] [Full Text] [Related]

  • 19. Views of Australian mental health stakeholders on clients' problematic drug and alcohol use.
    Cleary M, Hunt GE, Matheson S, Walter G.
    Drug Alcohol Rev; 2009 Mar; 28(2):122-8. PubMed ID: 19320696
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.